AM095

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AM095

CAS No. : 1345614-59-6

MCE 国际站：AM095

产品活性：AM095 是一种选择性的 LPA₁ 受体拮抗剂。作用于人和鼠 转染 LPA₁ 的 CHO 细胞，AM095 拮抗 LPA 诱导的钙流动，IC₅₀ 分别为 0.025 和 0.023 μM。

研究领域：GPCR/G Protein

作用靶点：LPL Receptor

In Vitro: AM095 is a potent LPA₁ receptor antagonist because it inhibits GTPγS binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA₁ with IC₅₀ values of 0.98 and 0.73 μM, respectively. AM095 inhibits LPA-driven chemotaxis of CHO cells overexpressing mouse LPA₁ (IC₅₀=778 nM) and human A2058 melanoma cells (IC₅₀=233 nM). The IC₅₀ of AM095 in the human LPA₁ GTPγS binding assay is comparable with that of our previously published compound AM966 (IC₅₀=0.98±0.17 μM) and the Debio-0719 compound (IC₅₀=0.60±0.04 μM). AM095 inhibits the LPA-induced calcium flux of CHO cells stably transfected with human or mouse LPA₁. The IC₅₀ for AM095 antagonism of LPA-induced calcium flux of human or mouse LPA₁-transfected CHO cells is 0.025 and 0.023 μM, respectively.

In Vivo: AM095 has high oral bioavailability and a moderate half-life and is well tolerated at the doses tested in rats and dogs after oral and intravenous dosing. After oral (10 mg/kg) dosing in rats, AM095 plasma concentrations peaked at 2 h with a C_max of 41 μM, thereafter decreasing to 10 nM by 24 h. After intravenous (2 mg/kg) dosing, a C_max of 12 μM is observed within 15 min, which also decreased to approximately 10 nM by 24 h, yielding a t_1/2 of 1.79 h. In dogs, a single oral dose of 5 mg/kg yielded a peak plasma concentration of 21 μM within 15 min of dosing, which then decreased to 10 nM by 24 h. In contrast, an intravenous dose of 2 mg/kg resulted in a C_max of 11 μM within 15 min and decreased to 15 nM by 8 h, yielding a t_1/2 of 1.5 h.

相关产品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Fingolimod hydrochloride  |  Sphingosine-1-phosphate  |  MK-571 sodium  |  Siponimod  |  Poloxamer 407  |  Ki16425  |  JTE-013  |  Ozanimod  |  PF-543 Citrate  |  BMS-986020  |  1-Oleoyl lysophosphatidic acid sodium  |  BMS-986278  |  SEW​2871  |  Etrasimod  |  Ponesimod  |  SLF1081851  |  AM966  |  TY-52156  |  W146 TFA  |  CAY10444  |  CYM50358  |  AS2717638  |  CYM-5520  |  CRT0273750  |  CYM-5541  |  CYM5442  |  H2L5186303

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds